Tau Drug Heads into Phase 3 Trials in Frontotemporal Dementia, Alzheimer's
Friday, October 5, 2012 - 13:01
in Psychology & Sociology
A small company with roots in Singapore and Scotland plans to test a relatively unknown compound in clinical trials for a type of dementia that strongly affects behavior.